Nazione: Nuova Zelanda
Lingua: inglese
Fonte: Medsafe (Medicines Safety Authority)
Aciclovir 800mg;
Douglas Pharmaceuticals Limited
Aciclovir 800 mg
800 mg
Dispersible tablet
Active: Aciclovir 800mg Excipient: Colloidal silicon dioxide Magnesium stearate Microcrystalline cellulose Pregelatinised maize starch Purified water Sodium starch glycolate
Blister pack, 35 tablets
Prescription
Prescription
Zhejiang Charioteer Pharmaceutical Co. Ltd
· Treatment of Herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · Suppression (prevention of recurrences) of recurrent Herpes simplex infections in immune-competent patients. · Prophylaxis of Herpes simplex infections in immune-competent patients. · Treatment of acute Herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · Management of patients with severe AIDS who have a CD4 count of less than 50/µL. Studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced HIV disease. · Patients undergoing allogenic bone marrow transplantation who are at risk of developing CMV infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). Studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. In addition oral aciclovir provided effective prophylaxis for herpes virus disease.
Package - Contents - Shelf Life: Blister pack, - 35 tablets - 36 months from date of manufacture stored at or below 25°C
1997-06-16
CONSUMER MEDICINE INFORMATION LOVIR _aciclovir _ 200 mg, 400 mg and 800 mg dispersible tablets. WHAT IS IN THIS LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TAKING LOVIR. This leaflet answers some common questions about LOVIR 200 mg, 400 mg and 800 mg tablets. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking LOVIR against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING LOVIR 200 MG, 400 MG AND 800 MG TABLETS, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT LOVIR TABLETS ARE USED FOR LOVIR tablets contain the active ingredient aciclovir. Aciclovir belongs to a group of medicines called “anti-virals”. LOVIR works by stopping the herpes virus being able to reproduce. The length and severity of an outbreak of herpes is therefore reduced. Long term use of LOVIR can reduce the number of herpes outbreaks in people who experience this condition often. LOVIR does not get rid of the herpes virus from your body. Your doctor may have prescribed LOVIR tablets for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY LOVIR HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor's prescription. BEFORE YOU TAKE LOVIR TABLETS _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE LOVIR IF YOU HAVE AN ALLERGY TO: • any medicine containing aciclovir or a class of medicines called “anti-virals”. • any of the ingredients listed at the end of this leaflet Some of the symptoms of an allergic reaction may include: • difficulty in breathing or wheezing • shortness of breath • swelling of the face, tongue, lips or other parts of the body • hives on the skin, rash, or itching. DO NOT TAKE THIS MEDICINE IF YOU ARE PREGNANT. It may affect your developing baby if you take it during pregnancy. DO NOT BREASTFEED IF YOU ARE TAKING THIS MEDICINE. T Leggi il documento completo
1 | P a g e NEW ZEALAND DATA SHEET 1. PRODUCT NAME LOVIR® Dispersible tablet, 200 mg LOVIR® Dispersible tablet, 400 mg LOVIR® Dispersible tablet, 800 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each LOVIR 200 mg Dispersible tablet contains aciclovir 200 mg. Each LOVIR 400 mg Dispersible tablet contains aciclovir 400 mg. Each LOVIR 800 mg Dispersible tablet contains aciclovir 800 mg. EXCIPIENT(S) WITH KNOWN EFFECT For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM LOVIR 200 mg: White to off-white capsule shaped, biconvex uncoated tablet with “200” debossed on one side and “ACV” on the other side. LOVIR 400 mg: White to off-white capsule shaped, biconvex uncoated tablet with “400” debossed on one side and “ACV” on the other side. LOVIR 800 mg: White to off-white capsule shaped, biconvex uncoated tablet with “800” debossed on one side and “ACV” on the other side. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS LOVIR Dispersible tablets are indicated for: • Treatment of Herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. • Suppression (prevention of recurrences) of recurrent Herpes simplex infections in immune-competent patients. • Prophylaxis of Herpes simplex infections in immune-compromised patients. • Treatment of acute Herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster-associated pain and for the reduction of the incidence and duration of post-herpetic neuralgia. 2 | P a g e • Management of patients with severe AIDS who have a CD4 count of less than 50/μL. Studies have shown that oral aciclovir given in conjunction with anti-retroviral therapy reduced mortality in patients with advanced HIV disease. • Patients undergoing allogenic bone marrow transplantation who are at risk of developing CMV infection while immunosuppressed (preceded by one month’s treatment with intravenous aciclovir). Stu Leggi il documento completo